U.S. to limit states’ access to COVID antibody treatments as demand rises … Aggressively reducing Alzheimer’s risk factors could mean 1.2 million fewer cases in 2050: experts … NIH launches nationwide...
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Clinical briefs for Monday, Aug. 23
By
Alicia Lasek
Aug 23, 2021
FDA pushing to fully approve Pfizer COVID vaccine this week … Accessible strength training nearly equals effect of drugs in lowering blood pressure, experts find … Need for yearly COVID shot may not...
Clinical briefs for Monday, June 28
By
Alicia Lasek
Jun 28, 2021
To save itself, Medicare could deny coverage of controversial new Alzheimer’s drug, expert predicts … Aduhelm most appropriate for early dementia, MCI, experts say … Eli Lilly to seek early approval...
SNF-linked wound clinics saw fewer patients during pandemic but unchanged outcomes
By
Alicia Lasek
Nov 10, 2021
Investigators expected that wound outcomes would be adversely affected by pandemic disruptions. But data from hundreds of wound care clinics in the United States show otherwise.
Nursing home study reveals ‘dramatic’ fluctuations in prescribing of COVID-19 meds
By
Alicia Lasek
May 26, 2023
Investigators tracked the use of COVID-19 medications in 11 U.S. nursing home chains, describing prescribing patterns that shed new light on the challenges of pandemic clinical care.
Free LTC infection prevention tool from Yale aims to help nursing home staff save time
By
Alicia Lasek
Nov 09, 2021
A one-stop set of infection prevention resources is meant to make work a bit easier for direct care providers, administrators, managers and support staff, say the Yale School of Nursing and the New York...
Alzheimer’s blood test to be used in memory-loss prevention trial
By
Alicia Lasek
Nov 12, 2021
The PrecivityAD blood test will lower barriers to participation in a new clinical trial that aims to prevent the symptoms of Alzheimer’s disease, researchers say.
Clinical briefs for Monday, June 5
By
Alicia Lasek
Jun 05, 2023
Memory support neighborhood takes ‘dignified approach’ to dementia care … Bias in test of lung function leaves up to 40% of Black males undiagnosed … FDA revokes EUA for J&J’s COVID vaccine...
COVID-19 may be a new risk factor for chronic pain, national study finds
By
Alicia Lasek
Jun 30, 2023
Fully 26% of study participants with moderate to severe COVID-19 symptoms reported frequent pain, researchers report.